A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
David Jayne, Niels Rasmussen, K. Andrássy, Paul Bacon, Jan Willem Cohen Tervaert, Jolanta Dadonienė, Agneta Ekstrand, Gill Gaskin, Gina Gregorini, Kirsten de Groot, Wolfgang L. Gross, E. Christiaan Hagen, E Mirapeix, E Pettersson, C. E. H. Siegert, Alberto Sinico, Vladimı́r Tesař, Kerstin Westman, Charles D. Pusey
New England Journal of Medicine, 2003
Abstract
This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
- Genetically Distinct Subsets within ANCA-Associated Vasculitis 2012
- Current Landscape of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 2014
- Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis 2018
- THU0301 Safety following initiation of rituximab in granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA): interim analysis of the rituximab in anca-associated vasculitis registry (RAVER) 2017
- AB0098 ASSOCIATED FACTORS IN ONE-YEAR MORTALITY IN PATIENTS WITH SMALL VESSEL SYSTEMIC VASCULITIS 2021
- Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis 1998
- Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups 2002
- Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis 1997
- Therapy for the maintenance of remission in sixty‐five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole 1996
- Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis 1995